1,020
Views
5
CrossRef citations to date
0
Altmetric
Articles

Downregulation of lysosomal and further gene expression characterization in lung cancer patients with bone metastasis

, , , &
Pages 758-764 | Received 30 Apr 2016, Accepted 02 Jun 2016, Published online: 09 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xue Dong, Shaohua Zou, Chunjing Guo, Kaili Wang, Feng Zhao, Huaying Fan, Jungang Yin & Daquan Chen. (2018) Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 168-177.
Read now
Azam Sargazi, Naeem Kamali, Fereshteh Shiri & Mostafa Heidari Majd. (2018) Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone. Artificial Cells, Nanomedicine, and Biotechnology 46:3, pages 500-509.
Read now

Articles from other publishers (3)

Sung Bae Park & Changwon Yoo. (2022) Development of a graphical model of causal gene regulatory networks using medical big data and Bayesian machine learning. Journal of the Korean Medical Association 65:3, pages 167-172.
Crossref
Olga Kelemen, Indira Pla, Aniel Sanchez, Melinda Rezeli, Attila Marcell Szasz, Johan Malm, Viktoria Laszlo, Ho Jeong Kwon, Balazs Dome & Gyorgy Marko‐Varga. (2020) Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas. Clinical and Translational Medicine 10:2.
Crossref
Chien-Ming Liu, Huan-Ting Shen, Yi-An Lin, Yung-Luen Yu, Yong-Syuan Chen, Chung-Jung Liu & Yi-Hsien Hsieh. (2020) Antiproliferative and Antimetastatic Effects of Praeruptorin C on Human Non–Small Cell Lung Cancer through Inactivating ERK/CTSD Signalling Pathways. Molecules 25:7, pages 1625.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.